United Therapeutics Corporation Logo

United Therapeutics Corporation

🇺🇸
UTHR
US91307C1027

United Therapeutics Corporation is a U.S. biopharmaceutical company dedicated to developing innovative therapies for patients with life-threatening diseases. A primary focus is on lung diseases such as pulmonary arterial hypertension (PAH) and improving organ transplantation. The company researches and develops groundbreaking medicines to extend and improve the lives of its patients.

Next Quarterly Earnings

Wednesday, August 5, 2026
CW 32
Pre-Market
In 31 days

Stock Price

All Dates

Company Information

Name
United Therapeutics Corporation
Ticker Symbol
UTHR
ISIN
US91307C1027
Country
🇺🇸
USA